Vishnu Chemicals Ltd
Incorporated in 1989, Vishnu Chemicals
Limited is in the business of manufacturing, marketing and export of Chromium chemicals and Barium compounds across the world.
Located in Hyderabad, the company is serving more than 12 industries across 57 countries globally.
- Market Cap ₹ 2,666 Cr.
- Current Price ₹ 407
- High / Low ₹ 562 / 247
- Stock P/E 26.2
- Book Value ₹ 116
- Dividend Yield 0.07 %
- ROCE 20.0 %
- ROE 18.1 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 32.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.7%
Cons
- Promoter holding has decreased over last 3 years: -6.64%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,287 | |
339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,081 | |
Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 205 |
OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% |
1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 14 | |
Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 37 |
Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 36 |
Profit before tax | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 146 |
Tax % | 36% | 41% | 52% | 35% | 35% | 27% | -1% | 28% | 26% | 30% | |
22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 102 | |
EPS in Rs | 3.66 | 3.56 | 1.10 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 15.54 |
Dividend Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 21% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 43% |
TTM: | -15% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 80% |
3 Years: | 32% |
1 Year: | 29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 28% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 |
Reserves | 79 | 106 | 85 | 99 | 130 | 148 | 184 | 265 | 402 | 688 | 747 |
225 | 263 | 322 | 381 | 348 | 328 | 336 | 365 | 379 | 315 | 342 | |
177 | 239 | 275 | 289 | 266 | 247 | 242 | 274 | 258 | 310 | 358 | |
Total Liabilities | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,460 |
186 | 202 | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 616 | |
CWIP | 44 | 66 | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 51 |
Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 0 |
262 | 352 | 342 | 415 | 387 | 360 | 361 | 444 | 488 | 675 | 793 | |
Total Assets | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,460 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
13 | 39 | 73 | 89 | 100 | 49 | 67 | 94 | 134 | 68 | |
-9 | -43 | -98 | -33 | -23 | -22 | -52 | -86 | -118 | -154 | |
1 | 4 | 25 | -56 | -78 | -24 | -19 | -9 | -16 | 88 | |
Net Cash Flow | 5 | -1 | 0 | 0 | -1 | 4 | -4 | 0 | 0 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 |
Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 |
Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 |
Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 |
Working Capital Days | 128 | 103 | 58 | 83 | 72 | 78 | 92 | 64 | 62 | 102 |
ROCE % | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - Analyst/Institutional Investor Meeting scheduled on 18th Dec.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - Analyst/Institutional Investor Meeting - Disclosure Regulation 30 of the SEBI (LODR) Regulations, 2015 is enclosed.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Dec - Analyst/Institutional Investor Meeting - Disclosure Regulation 30 of the SEBI (LODR) Regulations, 2015 is enclosed.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Dec - Schedule of Analyst/Institutional Investor Meeting.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
30 Nov - Completion of acquisition of Jayansree Pharma Private Limited.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Nov 2021Transcript PPT
Products & Usage [1]
The company deals in two compounds which are: